Drug intelligence / Profile preview

bupivacaine + lidocaine + methylprednisolone acetate + alcohol

Development stage
Unknown
Lead developer
Advanced Rx of Tennessee
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intraarticular, Intralesional, Intramuscular, Soft Tissue Injection, Topical
01

Overview

This is a multi-component injectable pharmaceutical kit containing bupivacaine hydrochloride, lidocaine hydrochloride, methylprednisolone acetate, and isopropyl alcohol. Bupivacaine and lidocaine are amide-type local anesthetics that block sodium channels in neuronal membranes to inhibit nerve impulse conduction, providing local or regional anesthesia and analgesia. Methylprednisolone acetate is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties; it acts by binding to the glucocorticoid receptor to modulate gene expression and suppress inflammatory mediators. Isopropyl alcohol serves as an antiseptic component in the formulation. This combination is used for intra-articular, intralesional, intramuscular, soft tissue injection or topical application for pain management (including postsurgical analgesia), inflammation control (such as in arthritis), or other conditions requiring both local anesthesia and corticosteroid effect[5][1][2]. The product may also contain additional excipients such as povidone-iodine and sodium chloride depending on the specific kit.

Brand names
Dyural 40 KitDyural40 KitDyural-40 KitDyural 80 KitDyural80 KitDyural-80 Kit
02

Targets

GR (Glucocorticoid receptor)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on bupivacaine + lidocaine + methylprednisolone acetate + alcohol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + lidocaine + methylprednisolone acetate + alcohol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call